Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) has been given an average rating of “Buy” by the seven brokerages ...
Tourmaline Bio (NASDAQ:TRML – Get Free Report) had its price objective lifted by analysts at HC Wainwright from $49.00 to $50.00 in a research report issued on Friday,Benzinga reports. The firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results